醫思健康(02138.HK)香港自建旗艦寵物醫院開幕
醫思健康(02138.HK)公布,旗下首個於香港自建的旗艦寵物醫院「動物醫療學會醫院」(AMAH)已於近日開幕。該醫院位於尖沙咀,總面積超過2.6萬呎,除提供獸醫全科門診服務外,亦提供麻醉專科、神經專科及心臟專科在內的獸醫專科門診服務。
醫院內設10間診症室、8間手術預備及恢復監控室、14間化療病房、18間深切治療病房、59間貓狗住院病房及自用氧機房,可為寵物提供包括磁力共振,電腦掃描及心臟超聲波在內的高端影像服務。
醫思健康執行董事兼首席財務官李向榮表示,公司自2021年進入獸醫領域,積極進行市場整合,透過企業化賦能傳統的獸醫資產提升營運效率,未來將著力發展獸醫業務,推動獸醫業務成為集團業績新增長引擎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.